Skip to main content

Table 2 Study A; Number of Patients with Treatment-Related Toxicities and Study B; Number of Patients with Treatment-Related Toxicities

From: Inhibition of the mammalian target of rapamycin (mTOR) in advanced pancreatic cancer: results of two phase II studies

A   
Toxicities Grade 3 or 4 Grade 5
Study A   
Hemorrhagic stroke - 1
Pain 2 -
Fatigue 1 -
Constipation 1 -
Anorexia 1 -
Deep vein thrombosis 1 -
B
Study B Grade 2 Grade 3 or 4
Neutropenia 2 -
Hyponatremia - 1
Diarrhea - 1
Fatigue - 1
Hyperglycemia - 1
Mucositis 2 -
Pneumonia 2 -
Dehydration 2 -
Nausea 2 -
Rash 2 -